This topic contains a solution. Click here to go to the answer

Author Question: A client is ordered to receive carisoprodol (Soma) for muscle relaxation. The client takes the ... (Read 73 times)

jeatrice

  • Hero Member
  • *****
  • Posts: 543
A client is ordered to receive carisoprodol (Soma) for muscle relaxation. The client takes the medication for 3 weeks and then abruptly stops. The client is at increased risk for:
 
  a. excessive muscle relaxation.
  b. decreased range of motion.
  c. increased inflammation.
  d. rebound muscle spasms.

Question 2

A client with myasthenia gravis is noted to be salivating, tearing, and sweating. The client complains of muscle weakness. What would the nurse anticipate administering?
 
  a. Pyridostigmine bromide
  b. Neostigmine
  c. Edrophonium
  d. Atropine sulfate



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

katkat_flores

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

ANS: D
Rebound spasms may occur if carisoprodol (Soma) is stopped abruptly.

Answer to Question 2

ANS: D
These are the major signs of cholinergic crisis; the client would be treated with the antidote, atropine sulfate.




jeatrice

  • Member
  • Posts: 543
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


ricroger

  • Member
  • Posts: 352
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

The first successful kidney transplant was performed in 1954 and occurred in Boston. A kidney from an identical twin was transplanted into his dying brother's body and was not rejected because it did not appear foreign to his body.

Did you know?

Bacteria have been found alive in a lake buried one half mile under ice in Antarctica.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library